NasdaqGM - Delayed Quote USD

XOMA Corporation (XOMA)

25.36 -0.28 (-1.09%)
At close: April 25 at 4:00 PM EDT
Loading Chart for XOMA
DELL
  • Previous Close 25.64
  • Open 25.55
  • Bid --
  • Ask --
  • Day's Range 25.20 - 26.75
  • 52 Week Range 13.48 - 27.00
  • Volume 5,222
  • Avg. Volume 18,772
  • Market Cap (intraday) 295.064M
  • Beta (5Y Monthly) 0.59
  • PE Ratio (TTM) --
  • EPS (TTM) -4.04
  • Earnings Date May 7, 2024 - May 13, 2024
  • Forward Dividend & Yield 2.16 (8.50%)
  • Ex-Dividend Date Apr 2, 2024
  • 1y Target Est --

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

www.xoma.com

13

Full Time Employees

December 31

Fiscal Year Ends

Recent News: XOMA

Performance Overview: XOMA

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

XOMA
37.08%
S&P 500
5.84%

1-Year Return

XOMA
39.65%
S&P 500
22.03%

3-Year Return

XOMA
31.99%
S&P 500
20.77%

5-Year Return

XOMA
107.70%
S&P 500
72.46%

Compare To: XOMA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: XOMA

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    295.06M

  • Enterprise Value

    266.11M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    61.14

  • Price/Book (mrq)

    3.33

  • Enterprise Value/Revenue

    55.93

  • Enterprise Value/EBITDA

    -6.76

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -7.30%

  • Return on Equity (ttm)

    -38.39%

  • Revenue (ttm)

    4.76M

  • Net Income Avi to Common (ttm)

    -46.3M

  • Diluted EPS (ttm)

    -4.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    153.45M

  • Total Debt/Equity (mrq)

    140.27%

  • Levered Free Cash Flow (ttm)

    4.37M

Research Analysis: XOMA

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: XOMA

Fair Value

25.36 Current
 

Dividend Score

0 Low
XOMA
Sector Avg.
100 High
 

Hiring Score

0 Low
XOMA
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
XOMA
Sector Avg.
100 High
 

Research Reports: XOMA

  • Daily – Vickers Top Buyers & Sellers for 09/28/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 09/19/2022

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Buyers & Sellers for 04/05/2021

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     

People Also Watch